{
    "cancelStatus": "1",
    "cancelDate": "2013-01-18",
    "cancelReason": [
        "838"
    ],
    "licid": "06016134",
    "validDate": "2011-03-13 00:00:00.000",
    "issueDate": "2006-03-13 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00601613404",
    "prodNameC": "邦迪斯人類抗心脂酵素免疫球蛋白G免疫分析套組",
    "prodNameE": "THE BINDING SITE BINDAZYMETM Human Anticardiolipin IgG Enzyme Immunoassay Kit",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "Instruction Leaflet: Giving full assay details.\\nQC Certificate: Indicating the expected performance of the batch.\\nCardiolipin Coated Wells: 12 breakapart 8 well strips coated with bovine cardiolipin antigen.\\nType II Sample Diluent: 2 bottles containing 50 ml of buffer for sample dilution.\\nType II Wash Buffer (20x concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\\nCardiolipin IgG Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anticardiolipin autoantibody: 100, 50, 25, 12.5, 6.25 MPL U\/ml.\\nCardiolipin IgG Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\\nCardiolipin Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\\nCardiolipin IgG Conjugate: 1 bottle containing 12 ml of purified peroxidase labeled antibody.\\nTMB Substrate: 1 bottle containing 14 ml TMB substrate."
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "太暘生物科技股份有限公司",
    "applicantAddr": "新北市汐止區康寧街169巷25號13樓",
    "medClass": "2",
    "efficacy": "測量人類血清中抗牛心脂蛋白抗體G型免疫球蛋白之濃度，有助於抗磷脂質症候群的診斷。 ",
    "mdFormat": "MK027",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "C",
            "mdKindMCodeName": "C 免疫學及微生物學裝置",
            "mdKindDCode": "C.5660",
            "mdKindDCodeName": "C.5660 多發性自體抗體免疫試驗系統",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "THE BINDING SITE LIMITED.",
            "factoryAddr": "WARSTOCK ROAD, KINGS HEATH, BIRMINGHAM, B14 4RT, UNITED KINGDOM",
            "factoryCompanyAddr": null,
            "countryCode": "GB",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MGB0210000",
            "factoryInfo": "4",
            "qsd": null
        },
        {
            "factoryCode": "2",
            "factoryName": "THE BINDING SITE LIMITED.",
            "factoryAddr": "P. O. BOX 11712, BIRMINGHAM, B14 4ZB, UNITED KINDOM",
            "factoryCompanyAddr": null,
            "countryCode": "GB",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "E",
            "factoryNo": "MGB0204000",
            "factoryInfo": "4",
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Instruction Leaflet: Giving full assay details.\\nQC Certificate: Indicating the expected performance of the batch.\\nCardiolipin Coated Wells: 12 breakapart 8 well strips coated with bovine cardiolipin antigen.\\nType II Sample Diluent: 2 bottles containing 50 ml of buffer for sample dilution.\\nType II Wash Buffer (20x concentrate): 1 bottle containing 50 ml of a 20-fold concentrated buffer for washing the wells.\\nCardiolipin IgG Calibrators: 5 bottles each containing 1.2 ml of diluted human serum, with the following concentrations of anticardiolipin autoantibody: 100, 50, 25, 12.5, 6.25 MPL U\/ml.\\nCardiolipin IgG Positive Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\\nCardiolipin Negative Control: 1 bottle containing 1.2 ml of diluted human serum. The expected value is given on the QC certificate.\\nCardiolipin IgG Conjugate: 1 bottle containing 12 ml of purified peroxidase labeled antibody.\\nTMB Substrate: 1 bottle containing 14 ml TMB substrate.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": []
}